NXL Nexalin Technology, Inc.
Data as of close
Healthcare · Electromedical & Electrotherapeutic Apparatus
Nexalin Technology, Inc. (NXL) is a healthcare company in the Electromedical & Electrotherapeutic Apparatus industry, with a market capitalization of $1 million. Shares last traded at $1.50, 96.6% below their 52-week high. Over the past year the stock is down 96.6%. Revenue grew 78.8% year over year.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. NXL split history →
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | -$3.30 | 2026-08-12 |
| Q1 2026 | -$3.30 | 2026-05-08 |
| Q4 2025 (derived) | -$3.60 | 2026-03-25 |
| FY 2025 | -$15.00 | 2026-03-25 |
| Q3 2025 | -$3.90 | 2025-11-14 |
| Q2 2025 | -$3.00 | 2025-08-06 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Electromedical & Electrotherapeutic Apparatus peers
NXL vs 14 industry peers (Electromedical & Electrotherapeutic Apparatus), by market cap. Data as of close
| MDT | Medtronic | $126.5B | 24.18 | 3.37 | 13.9% | -0.41% |
| LIVN | Livanova Plc | $4.4B | 23.40 | 3.00 | 12.8% | -0.17% |
| ITGR | Integer Holdings Corp | $4.3B | 41.51 | 2.36 | 5.7% | +0.03% |
| AXGN | Axogen, Inc. | $3.0B | — | 11.08 | -12.0% | -0.68% |
| TMDX | Transmedics Group, Inc. | $2.3B | 15.41 | 3.50 | 22.7% | +1.32% |
| CNMD | Conmed Corp | $1.4B | 29.96 | 1.03 | 3.4% | +1.60% |
| CBLL | Ceribell, Inc. | $1.1B | — | 10.11 | -68.0% | +4.91% |
| INMD | Inmode Ltd. | $893M | 9.51 | 2.41 | 25.3% | +2.92% |
| CV | CapsoVision, Inc | $335M | — | — | — | -0.74% |
| ELMD | Electromed, Inc. | $224M | 19.85 | 3.04 | 15.3% | +0.02% |
| FOCL | EDAP TMS SA | $162M | — | 2.29 | -41.5% | +0.35% |
| VANI | Vivani Medical, Inc. | $96M | — | 201.30 | — | -3.20% |
| STXS | Stereotaxis, Inc. | $85M | — | 2.83 | -74.2% | -3.42% |
| NRXS | Neuraxis, INC | $83M | — | — | — | -0.45% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.